One-year single-center follow-up study of ustekinumab and vedolizumab use in inflammatory bowel disease Egyptian patients as second-line therapy after anti-TNF failure
一项为期一年的单中心随访研究，评估了乌司奴单抗和维多珠单抗作为抗TNF治疗失败后二线疗法在埃及炎症性肠病患者中的应用。
期刊:Przeglad Gastroenterologiczny
影响因子:2.5
doi:10.5114/pg.2025.156473
Kamel, Shimaa; Alaty, Waleed Hamed Abd; Rashad, Heba; Fathy, Dina; Abdel-Samiee, Mohamed; Hindy, Ibrahim; Shaban, Ahmed; Askar, Safaa
